GNI Group Ltd
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. The company offers Etuary for the treatment of idiopathic pulmonary fibrosis. It is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue-associated interstitial lung disease; and in clinical trial pre-phase III clinical tri… Read more
GNI Group Ltd (3G6) - Total Assets
Latest total assets as of June 2025: €67.72 Billion EUR
Based on the latest financial reports, GNI Group Ltd (3G6) holds total assets worth €67.72 Billion EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
GNI Group Ltd - Total Assets Trend (2013–2024)
This chart illustrates how GNI Group Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
GNI Group Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
GNI Group Ltd's total assets of €67.72 Billion consist of 40.6% current assets and 59.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 14.1% |
| Accounts Receivable | €6.24 Billion | 8.7% |
| Inventory | €2.53 Billion | 3.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €11.03 Billion | 15.3% |
| Goodwill | €15.99 Billion | 22.2% |
Asset Composition Trend (2013–2024)
This chart illustrates how GNI Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: GNI Group Ltd's current assets represent 40.6% of total assets in 2024, a decrease from 79.4% in 2013.
- Cash Position: Cash and equivalents constituted 14.1% of total assets in 2024, down from 72.9% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 14.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 22.2% of total assets.
GNI Group Ltd Competitors by Total Assets
Key competitors of GNI Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
GNI Group Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - GNI Group Ltd generates 0.33x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, GNI Group Ltd generates $ 1.53 in net profit.
GNI Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.64 | 2.83 | 2.97 |
| Quick Ratio | 2.31 | 2.55 | 2.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €17.02 Billion | € 19.93 Billion | € 7.39 Billion |
GNI Group Ltd - Advanced Valuation Insights
This section examines the relationship between GNI Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.64 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 15.3% |
| Total Assets | €71.94 Billion |
| Market Capitalization | $772.60 Million USD |
Valuation Analysis
Below Book Valuation: The market values GNI Group Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: GNI Group Ltd's assets grew by 15.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for GNI Group Ltd (2013–2024)
The table below shows the annual total assets of GNI Group Ltd from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €71.94 Billion | +15.30% |
| 2023-12-31 | €62.39 Billion | +84.02% |
| 2022-12-31 | €33.91 Billion | +11.92% |
| 2021-12-31 | €30.30 Billion | +30.48% |
| 2020-12-31 | €23.22 Billion | +12.67% |
| 2019-12-31 | €20.61 Billion | +18.90% |
| 2018-12-31 | €17.33 Billion | +9.14% |
| 2017-12-31 | €15.88 Billion | +172.90% |
| 2016-12-31 | €5.82 Billion | -8.87% |
| 2015-12-31 | €6.38 Billion | -5.58% |
| 2014-12-31 | €6.76 Billion | +42.33% |
| 2013-12-31 | €4.75 Billion | -- |